PT Kimia Farma Tbk (ISX:KAEF) Construction In Progress: Rp10,743 Mil (As of Mar. 2026)


ISX:KAEF PT Kimia Farma Tbk ISX:KAEF
56 GF Score
Price Rp420.00
GF Value Rp581.83
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Kimia Farma Tbk Construction In Progress?

PT Kimia Farma Tbk ISX:KAEF -6.25% 56 Construction In Progress is Rp10,743 Mil as of Mar. 2026. GuruFocus rates ISX:KAEF with a GF Score™ of 56/100 and a GF Value™ of Rp581.83 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PT Kimia Farma Tbk's quarterly construction in progress declined from Sep. 2025 (Rp15,046 Mil) to Dec. 2025 (Rp6,136 Mil) but then increased from Dec. 2025 (Rp6,136 Mil) to Mar. 2026 (Rp10,743 Mil).

PT Kimia Farma Tbk's annual construction in progress declined from Dec. 2023 (Rp198,944 Mil) to Dec. 2024 (Rp100,177 Mil) and declined from Dec. 2024 (Rp100,177 Mil) to Dec. 2025 (Rp6,136 Mil).

PT Kimia Farma Tbk Construction In Progress Historical Data

* Premium members only.

The historical data trend for PT Kimia Farma Tbk's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kimia Farma Tbk Construction In Progress Chart

PT Kimia Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 597,762.33 789,219.10 198,944.16 100,176.68 6,135.74

PT Kimia Farma Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41,781.75 35,572.30 15,046.33 6,135.74 10,743.30
ISX:KAEF
56GF Score
PT Kimia Farma Tbk ISX:KAEF
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Kimia Farma Tbk Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of Rp10,743 Mil mean?
PT Kimia Farma Tbk (ISX:KAEF) has a Construction In Progress of Rp10,743 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on PT Kimia Farma Tbk and its competitors.
Is PT Kimia Farma Tbk's Construction In Progress too high?
PT Kimia Farma Tbk's current Construction In Progress is Rp10,743 Mil. Overall, PT Kimia Farma Tbk has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Tbk's Construction In Progress compare to MCK and CAH?
PT Kimia Farma Tbk's Construction In Progress of Rp10,743 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Distribution company?
A good Construction In Progress depends on the Medical Distribution industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on PT Kimia Farma Tbk and its competitors. PT Kimia Farma Tbk's current Construction In Progress is Rp10,743 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp581.83, compared to a current price of Rp420.00 — trading 27.8% below its estimated fair value. The current Construction In Progress is Rp10,743 Mil. PT Kimia Farma Tbk's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For PT Kimia Farma Tbk (ISX:KAEF), the current Construction In Progress is Rp10,743 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kimia Farma Tbk (ISX:KAEF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kimia Farma Tbk stock appears to be undervalued. The current stock price of Rp420.00 is trading 27.8% below its estimated GF Value™ of Rp581.83. GuruFocus considers PT Kimia Farma Tbk to be Modestly Undervalued.

Key valuation signals for ISX:KAEF:

  • Construction In Progress: Rp10,743 Mil
  • GF Value™: Rp581.83 vs. price of Rp420.00 (27.8% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Kimia Farma Tbk Business Description

Address Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
56GF Score

Get the complete analysis for ISX:KAEF

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp420.00
Price
Rp581.83
GF Value